An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever
Krasnianskiĭ, V.P.; Potryvaeva, N.V.; Borisevich, I.V.; Gradoboev, V.N.; Pashanina, T.P.; Pshenichnov, V.A.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 74-75
1994
ISSN/ISBN: 0372-9311 PMID: 7879553 Document Number: 433106
Document emailed within 1 workday
Related Documents
Imam, I.Z.; Darwish, M.A.; Hosny, A.H.; Amer, T. 1978: Serologic response of man to inactivated Rift Valley fever vaccine Journal of the Egyptian Public Health Association 53(3-4): 249-252Tokarevich, N.K.; Tarasevich, I.V. 2008: RAMS academician I. V. Tarasevich is a leader of development of combined inactivated vaccine against Q-fever Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2008(7): 19-24
Ikoev, V.N.; Gorbunov, M.A.; Vachaev, B.F.; Iagovkin, E.A.; Kondratenko, V.F.; Anan'ina, I.V.; Ansimova, T.I.; Kostina, N.I.; Iur'eva, I.L.; Nikitin, M.G. 1999: The evaluation of the reactogenicity and immunogenic activity of a new concentrated inactivated leptospirosis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 39-43
Kovalenko, V.N. 1971: Clinical effectiveness of inactivated cultural vaccine against tick-borne encephalitis and criteria for its evaluation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(7): 1006-1011
Vasil'eva, R.I.; Osidak, L.V.; Bichurina, M.A.; Mukhina, L.P.; Chudina, L.V. 1982: Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 96-98
Smit, A.M.; van der Heide, R.M. 1975: Lassa fever Nederlands Tijdschrift Voor Geneeskunde 119(7): 277-279
Adomajlo, A. 1976: Epidemiology of Lassa fever Przeglad Epidemiologiczny 30(2): 243-246
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Monat, T.P. 1977: Lassa fever, on-going problems and prospects Vestnik Akademii Meditsinskikh Nauk SSSR 5: 35-42
Krasniaskiĭ, V.P.; Gradoboev, V.N.; Borisevich, I.V.; Potryvaeva, N.V.; Lebedinskaia, E.V.; Chernikova, N.K.; Timan'kova, G.D. 1997: Development and study of immunoglobulins against Lassa fever Voprosy Virusologii 42(2): 71-74
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644
Monson, M.H.; Cole, A.K.; Frame, J.D.; Serwint, J.R.; Alexander, S.; Jahrling, P.B. 1987: Pediatric Lassa fever: a review of 33 Liberian cases American Journal of Tropical Medicine and Hygiene 36(2): 408-415
Frame, J.D.; Troup, J. 1992: The story of Lassa fever. Part II: Learning more about the disease New York State Journal of Medicine 92(6): 264-267
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Jennings, A.D.; Whitby, J.E.; Minor, P.D.; Barrett, A.D. 1993: Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses Vaccine 11(6): 679-681
Yamaguchi, T.; Tsuji, M.; Imagawa, Y. 1989: A first Lassa fever from Sierra Leone treated in high security ward Nihon Rinsho. Japanese Journal of Clinical Medicine 47(1): 76-81
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Tobin, E.A.; Asogun, D.A.; Esumeh, R.; Omuninu, R.; Ehidiamen, G.; Giwa, R. 2015: Knowledge of Secondary School Children in Edo State on Lassa Fever and its Implications for Prevention and Control West African Journal of Medicine 34(2): 101-107
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294
Iakubova, A.R.; Lagunov, V.M.; Faĭngol'd, Z.L. 1995: The possibility for obtaining sorbents from the mycelial wastes of antibiotic production Antibiotiki i Khimioterapiia 40(5): 35-37